Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

Tammara Brinda; Ryan Kelly; Plotka Anna; Shafer Frank E.; Wei Hua; Readett David; Fang Annie; Korth-Bradley Joan

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

【24h】

Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

机译：肾脏损伤对肾损伤和健康受试者氢普斯尔药代动力学和安全性的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
作者
Tammara Brinda; Ryan Kelly; Plotka Anna; Shafer Frank E.; Wei Hua; Readett David; Fang Annie; Korth-Bradley Joan;
展开▼
作者单位

Pfizer Inc Collegeville PA USA;

Pfizer Inc Collegeville PA USA;

Pfizer Inc Collegeville PA USA;

Pfizer Inc Collegeville PA USA;

Pfizer Inc Shanghai Peoples R China;

Pfizer Inc Groton CT 06340 USA;

Pfizer Inc New York NY USA;

Pfizer Inc Collegeville PA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects [J] . Tammara Brinda, Ryan Kelly, Plotka Anna, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：肾脏损伤对肾损伤和健康受试者氢普斯尔药代动力学和安全性的影响
2. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis [J] . RiccobeneT., JakateA., RankD. The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2014,第7期

机译：ceftaroline fosamil在特定人群中的一系列药代动力学研究：正常受试者，健康老年受试者以及需要血液透析的肾功能不全或终末期肾脏疾病的受试者
3. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis [J] . RiccobeneT., JakateA., RankD. The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2014,第7期

机译：精选群体中Ceftaroline Fosamil的一系列药代动力学研究：正常受试者，健康的老年人，肾脏损伤或肾脏损伤的受试者需要血液透析
4. Comparison of Urinary Crystallites from Patients with Renal Calculi with that from Healthy Subjects [C] . Zhi-Yue XIA, Yi-Ming DING, Jian-Ming OUYANG International Conference on Chemical Engineering and Advanced Materials . 2012

机译：从健康受试者肾结石患者尿液结晶的比较
5. Design evaluation for pharmacokinetic studies in patients with renal impairment [D] . Liu, Jin 2007

机译：肾功能不全患者药代动力学研究的设计评估
6. Pharmacokinetics Safety and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects [O] . John O’Donnell, Richard A. Preston, Grigor Mamikonyan, 2019

机译：肾功能不全受试者和健康对照受试者的静脉注射地洛他坦和舒巴坦的药代动力学安全性和耐受性
7. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients [O] . Agersø, Henrik, Seiding Larsen, Lotte, Riis, Anders, 2004

机译：静注去氨加压素对健康受试者和肾功能不全患者的药代动力学和肾脏排泄

Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

著录项

相似文献

相关主题

期刊订阅